SomaLogic, Inc. stock is up 10% since 30 days ago. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 0% of the previous 2 December’s closed higher than November.
SomaLogic, Inc. develops slow off-rate modified aptamers (SOMAmers), which are modified nucleic acid-based protein binding reagents that are specific for their cognate protein. It offers proprietary SomaScan services, which provide multiplex protein detection and quantification of protein levels in complex biological samples.